US · Healthcare · Diagnostics & Research
EPS came in at 4.99 against a street estimate of 4.79 — a beat of 4.2%.
Analysts rate Laboratory Corporation of America Holdings a buy (16 buy, 4 hold, 0 sell out of 20) with an average price target of $341.50.
CONFIDENT LH beat Q2 expectations with 5.8% revenue growth, 70bp margin expansion, and 15% EPS growth. Raised FY26 guidance on strength in specialty testing and Central Labs. Organic diagnostics growth of 3.6% outpaced market; early development stabilizing. Q2 2026 Call focused on enterprise and segments; no regional breakdown provided. Analysts probed organic-growth composition, early-development margin durability, and competitive positioning. Management emphasized quality-driven strategy, specialty/hospital focus over volume chase, and visibility into H2 through strong backlogs and study-start normalization. 2026-07-30…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.95% |
| Vanguard Capital Management, LLC | 6.63% |
| Victory Capital Management Inc. | 5.96% |
| State Street Corp | 4.76% |
| Vanguard Portfolio Management, LLC | 4.54% |
| Boston Partners Global Investors, Inc | 2.92% |
| Allspring Global Investments Holdings, LLC | 2.75% |
| Geode Capital Management, LLC | 2.70% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 LABCORP HOLDINGS INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No specific financial metrics disclosed in this Form 8-K filing itself • Company reaffir | 2026-09-10 |
| Reg FD disclosure · Q3 2026 LABCORP HOLDINGS INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • No financial metrics provided – This is a regulatory disclosure document (Form 8-K) anno | 2026-08-28 |
| Reg FD disclosure · Q3 2026 LABCORP HOLDINGS INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • No financial results or specific numerical metrics provided in this document • Document | 2026-08-17 |
| Board / officer change · Q3 2026 LABCORP HOLDINGS INC. - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Megan D. Bailey resigned as Executive Vice President and President, Central | 2026-08-14 |
| Quarterly report · Q2 2026 LABCORP HOLDINGS INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue for six months ended June 30, 2026: $7,268.7 million (vs. $6,872.4 million i | 2026-08-05 |
| Results announced · Q3 2026 LABCORP HOLDINGS INC. – 2Q 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total Revenue: $3.73 billion (Q2 2026) vs. $3.53 billion (Q2 2025), up 5.8% • Di | 2026-07-30 |
| Quarterly report · Q1 2026 LABCORP HOLDINGS INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues Q1 2026: $3,537.6 million, up 5.8% from $3,345.1 million in Q1 2025 • | 2026-05-04 |
| Proxy statement · Q2 2026 LABCORP HOLDINGS INC. — 2026 PROXY STATEMENT SUMMARY --- WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect eleven director nominees to the Board | 2026-04-10 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.72 / share ex-date Aug 28, 2026 · pay Sep 11, 2026 | 2026-08-28 |
| Dividend | $0.72 / share ex-date May 29, 2026 · pay Jun 11, 2026 | 2026-05-29 |
| Dividend | $0.72 / share ex-date Feb 27, 2026 · pay Mar 12, 2026 | 2026-02-27 |
| Dividend | $0.72 / share ex-date Nov 26, 2025 · pay Dec 11, 2025 | 2025-11-26 |
| Dividend | $0.72 / share ex-date Aug 28, 2025 · pay Sep 11, 2025 | 2025-08-28 |
| Announcement | Date |
|---|---|
| Reaffirmed 2026 guidance and provided long-term financial outlook through 2029 Labcorp Holdings Inc. held its 2026 Investor Day on September 10, 2026, where management presented its growth strategy, innovation roadmap, and financial outlook through 2029. The company re | 2026-09-10 |
| Board declares cash dividend of $0.72 per share Labcorp Holdings Inc. announced a quarterly cash dividend of $0.72 per share, payable on September 11, 2026, to shareholders of record as of August 28, 2026. This is a routine dividend decla | 2026-07-10 |
| Board declares cash dividend of $0.72 per share Labcorp Holdings Inc. announced a quarterly cash dividend of $0.72 per share, payable on June 11, 2026, to shareholders on record as of May 29, 2026. This is a routine dividend declaration b | 2026-04-09 |
| Board declares cash dividend of $0.72 per share Labcorp Holdings Inc. announced a cash dividend of $0.72 per share, payable on March 12, 2026, to shareholders of record as of February 27, 2026. This is a routine capital allocation decisio | 2026-01-14 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Laboratory Corporation of America Holdings — free to start.
Google PlayApp StoreData updated 2026-09-18.